Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Journal of the American Chemical Society|March 12, 2019
A Focused DNA-Encoded Chemical Library for the Discovery of Inhibitors of NAD+-Dependent EnzymesLik Hang Yuen, Srikanta Dana, Yu Liu, et al.Journal of Medicinal Chemistry|April 1, 2024
Discovery of Novel Macrocyclic MERTK/AXL Dual InhibitorsDeyu Kong, Qiang Tian, Zhilong Chen, et al.Journal of Medicinal Chemistry|March 12, 2025
UNC9426, a Potent and Orally Bioavailable TYRO3-Specific InhibitorDeyu Kong, Xiangbo Yang, Samantha Judd, et al.SLAS Discovery : Advancing Life Sciences R & D|June 30, 2018
Identification of Cosalane as an Inhibitor of Human and Murine CC-Chemokine Receptor 7 Signaling via a High-Throughput ScreenEmily A Hull-Ryde, Melissa A Porter, Kenneth A Fowler, et al.ACS Infectious Diseases|July 6, 2016
Identification of small molecule inhibitors that block the Toxoplasma gondii rhoptry kinase ROP18Catherine Simpson, Nathaniel G Jones, Emily A Hull-Ryde, et al.SLAS Discovery : Advancing Life Sciences R & D|May 30, 2018
Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase InhibitorsAna C Puhl-Rubio, Michael A Stashko, Huanchen Wang, et al.ACS Medicinal Chemistry Letters|November 19, 2021
Discovery and Development of Cyclic Peptide Inhibitors of CIB1Victoria A Haberman, Steven R Fleming, Tina M Leisner, et al.European Journal of Medicinal Chemistry|May 26, 2021
UNC5293, a potent, orally available and highly MERTK-selective inhibitorHongchao Zheng, Jichen Zhao, Bing Li, et al.The Journal of Clinical Investigation|June 16, 2022
MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancerDan Yan, Justus M Huelse, Dmitri Kireev, et al.ACS Medicinal Chemistry Letters|December 21, 2016
Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase InhibitorsXiaodong Wang, Jing Liu, Weihe Zhang, et al.Pageof 6